Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Trevi Therapeutics Inc shares valued at $17,365 were sold by SCIASCIA THOMAS on Mar 25 ’25. At $6.60 per share, SCIASCIA THOMAS sold 2,631 shares. The insider’s holdings dropped to 221,373 shares worth approximately $1.53 million following the completion of this transaction.
Also, GOOD JENNIFER L sold 5,263 shares, netting a total of over 34,625 in proceeds. Following the sale of shares at $6.58 each, the insider now holds 213,313 shares.
Before that, GOOD JENNIFER L had added 5,263 shares to its account. In a trade valued at $34,625, the Officer bought Trevi Therapeutics Inc shares for $6.58 each.
As published in a research note from Raymond James on March 10, 2025, Trevi Therapeutics Inc [TRVI] has been rated up from an Outperform to a Strong buy and the price target has been revised to $29 from $9. Analysts at Needham resumed the stock at ‘”a Buy”‘ outlook in a report released in early March. As of December 12, 2024, H.C. Wainwright has reiterated its “Buy” rating for TRVI.
Analyzing TRVI Stock Performance
During the last five days, there has been a surge of approximately 10.21%. Over the course of the year, Trevi Therapeutics Inc shares have jumped approximately 67.72%. Shares of the company reached a 52-week high of $7.39 on 03/10/25 and a 52-week low of $3.47 on 01/22/25. A 50-day SMA is recorded $5.77, while a 200-day SMA reached $3.92.
Support And Resistance Levels for Trevi Therapeutics Inc (TRVI)
According to the 24-hour chart, there is a support level at 6.36, which, if violated, would cause prices to drop to 5.81. In the upper region, resistance lies at 7.24. The next price resistance is at 7.56. RSI (Relative Strength Index) is 65.51 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.45, which suggests the price will decrease in the coming days. Percent R is at 4.85%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
